Damir Vrabac
@dvrabac
Followers
147
Following
90
Media
0
Statuses
45
Co-Founder & COO @valarlabs
Stanford, CA
Joined September 2020
RT @JayRughani: We @a16z are thrilled to announce our Series A investment in @valarlabs, which is building AI tools to assist oncologists i….
0
17
0
RT @a16zBioHealth: Every year, nearly 2M new cancer diagnoses occur in the US alone and each diagnosis involves histological classification….
0
6
0
Read more about our Series A and our story in our blogpost: and check out our feature in TechCrunch by Devin Coldewey:
techcrunch.com
Biotech startup Valar Labs has built a tool that accurately predicts certain treatment outcomes, potentially saving precious time for patients.
0
0
0
We have many more exciting things on the horizon and are expanding our team across operations, commercial, clinical, and engineering. Join us to help build this future!
valarlabs.com
Everyone at Valar Labs helps to push the boundaries of cancer care. Join us and help create solutions for patients and physicians.
1
0
1
Also super excited to welcome @vintweeta and @hardimanjames to our board and continue working closely with @MarHershenson, @JayRughani, @JackBuendorf, @eddie_eltoukhy, and @VivHo.
1
0
1
Thrilled to be on this journey with my brilliant co-founders @anirrjoshi, @VisweshKrishna, and @pranavrajpurkar, and the entire Valar Team, along with all the dedicated physicians involved.
1
0
0
The funding will enable the commercial advancement of Vesta, and facilitate the expansion of our technology into other cancer types.
1
0
0
Vesta, the world’s first AI test to predict treatment response in bladder cancer, marks our initial step towards this future vision.
1
0
0
We aim to provide every patient and their physician with predictive tests that determine the most effective treatment based on individual characteristics, thereby maximizing their chances of successfully fighting cancer.
1
0
0
We started Valar with the mission to reduce the uncertainty of treatment decisions in cancer care.
1
0
0
Proud to announce a big milestone at @valarlabs : $22 million Series A, co-led by @DCVC and @a16zBioHealth, with continued support from @PearVC. Blogpost:
valarlabs.com
Co-led by DCVC and a16z, this funding will support the advancement of Vesta, world's first AI test to predict treatment response in bladder cancer, and catalyze expansion in other cancers.
1
0
0
RT @valarlabs: We're thrilled to collaborate with Dr. @ylotan and other esteemed urologists worldwide to validate #Vesta. Check out the int….
guoncologynow.com
Drs. Murray and Lotan review the development and validation of AI biomarkers to predict outcomes in BCG-treated NMIBC.
0
5
0
RT @valarlabs: Exciting news! Valar Labs is proud to announce #Vesta, the first histology-based test for predicting response to #BCG in #Bl….
businesswire.com
Valar Labs unveils a transformative computational histology AI assay for bladder cancer to enhance first-line treatment decision-making.
0
14
0
RT @a16zBioHealth: Technological transformations in healthcare have consistently empowered physicians and improved patient care. Examples i….
0
7
0
RT @pranavrajpurkar: 1/ 📢 New paper alert!. Pancreatic cancer lacks actionable biomarkers for precision therapy. We developed an AI-derive….
cell.com
Nimgaonkar et al. describe the identification of a histologic signature derived using artificial intelligence that stratifies patients receiving adjuvant gemcitabine for pancreatic cancer. The...
0
19
0
RT @valarlabs: 🚨 Excited to announce our work in AI prediction of gemcitabine backbone chemotherapy response in pancreatic cancer has been….
0
8
0
RT @valarlabs: We are excited to present at the Innovation Nexus at the #AUA23 on our AI diagnostics in urology. Wonderful working with gre….
0
7
0
RT @serinachang5: Excited to announce new work to appear at @RealAAAI '23! We study the problem of geographic spillovers, where people cros….
0
12
0
RT @PancPathologist: @valarlabs @DrHendifar @VisweshKrishna @UCSFCancer @CSCancerCare Excellent work by @valarlabs that uses #AI to battle….
0
5
0